Effect of GnRHa controlled ovarian hyperstimulation on mouse embryo implantation and its mechanism.
- Author:
Qiong WU
1
;
Hua-Zhou XU
1
;
Jiang-Xia YANG
1
;
Zhi-Li LI
1
;
Tian FU
1
;
Hui-Lan DU
1
;
Cui-Miao SONG
2
Author Information
1. Hebei University of Chinese Medicine, Collaborative Innovation Center of Integrated Chinese and Western Medicine on Reproductive Disease, Hebei Key Laboratory of Integrative Medicine on Liver-kidney Patterns, Shijiazhuang 050200, China.
2. Hebei University of Chinese Medicine, Collaborative Innovation Center of Integrated Chinese and Western Medicine on Reproductive Disease, Hebei Key Laboratory of Integrative Medicine on Liver-kidney Patterns, Shijiazhuang 050200, China. songcuimiao@126.com.
- Publication Type:Journal Article
- From:
Acta Physiologica Sinica
2018;70(5):489-496
- CountryChina
- Language:Chinese
-
Abstract:
The purpose of the present study was to investigate the effects and underlying mechanism of gonadotropin-releasing hormone agonist (GnRHa) controlled ovarian hyperstimulation (COH) on embryo implantation in mice. Forty female Kunming mice aged 9 weeks were randomly divided into two groups (control and COH groups). The COH group received intraperitoneal (i.p.) injections of aminocyclin acetate (GnRHa), human menopausal gonadotropin (HMG) and human chorionic gonadotropin (hCG), while the control group was given equal amount of physiological saline by i.p. injection. One male mouse and two female mice were put into the same cage at 16:00 on the hCG injection day, and on the fourth day of pregnancy, 10 mice from each group were killed. The levels of serum estradiol (E) and progesterone (P) were measured by radioimmunoassay; HE staining was used to observe the morphology of ovarian and endometrial tissues. The protein expression levels of endometrial leukemia inhibitory factor (LIF), phosphorylated signal transducer and activator of transcription 3 (p-STAT3), heparin-binding epidermal growth factor-like growth factor (HB-EGF) and glycodelin A were detected by Western blot and immunohistochemistry. Ten mice from each group were sacrificed on the eighth day of pregnancy, and the status of the uterus and the average number of blastocysts were observed. The results showed that, compared with control group, the serum E level in COH group was significantly decreased (P < 0.05), while the P level was increased significantly (P < 0.05); the ovarian follicles at different developmental stages were rare, corpus lutea (CL) were visible and multiple, the endometrium was thinned, and the number of endometrial glands was reduced (P < 0.05); the contents of LIF, p-STAT3, HB-EGF and glycodelin A in the endometrium were decreased significantly (P < 0.05) on the fourth day of pregnancy; mouse blastocysts developed slowly and were decreased in number on the eighth day of pregnancy (P < 0.05). The above results suggest that GnRHa COH can affect embryo implantation in mice. The mechanism may be related to the imbalance of gonadal hormone, the changes in the structure of the endometrium and the expressions of LIF, p-STAT3, HB-EGF and glycodelin A in the implantation stage, which may lead to the decrease of endometrial receptivity and the abnormal dialogue between the embryo and the uterus.
